Caltag is pleased to be sponsoring the Royal Microscopical Society (RMS)’s flowcytometryUK 2026! Location: Babraham Institute, Cambridge, CB22 3AT Date: Thursday 12 November 2026 Time: 9am – 5pm Event Information: https://www.rms.org.uk/rms-event-calendar/2026-events/flowcytometryuk-2026.html
Read MoreNews Feed
ESCCA 2026
Caltag is delighted to be sponsoring the European Society for Clinical Cell Analysis (ESCCA) 2026 meeting! Location: Salzburg Congress Centre, Auerspergstraße 6, 5020 Salzburg, Austria Date: Wednesday 9 September – Saturday 12 September 2026 Event Information: https://www.escca.eu/escca2026
Read MoreRMS Flow Cytometry Course 2026
Caltag is pleased to be sponsoring the Royal Microscopical Society (RMS)’s Flow Cytometry Course 2026! Location: Biology Department, University of York, York, YO10 5DD Date: Wednesday 8 July 2026 Time: 9am – 5:30pm Event Information: https://www.rms.org.uk/rms-event-calendar/2026-events/flow-cytometry-course-2026.html
Read MoreMidlands Innovation Flow Cytometry Conference 2026
Caltag is proud to be sponsoring the Midlands Innovation Flow Cytometry Conference 2026! Location: Edgbaston Park Hotel and Conference Centre, 53 Edgbaston Park Road, Birmingham, B15 2RS Date: Friday 6 March 2026 Time: 9am – 4pm Event Information/Registration: https://midlandsinnovation.org.uk/flow-cytometry-conference-2026/
Read MoreChanges at Cytomark and Caltag
Cytomark Ltd, as the owner of the IP and worldwide distribution rights for TransFix, is no longer operating and everything is now being transferred to Caltag Medsystems Ltd. Caltag is already the legal manufacturer of TransFix and now takes on …
Read MoreWhite Paper: Evaluation of TransFix/EDTA CSF Sample Storage Tubes compared to alternative preservation methods
Cytomark are pleased to announce the launch of their TransFix/EDTA CSF Sample Storage Tubes as CE marked in vitro diagnostic devices. Below we present finding on the effect of TransFix on cerebrospinal fluid samples, when compared to untreated samples, and …
Read MorePreservation of CD34+ Stem Cells and Precursors with TransFix
CD34+ population enumeration has multiple applications, for example to indicate whether a hematopoietic stem-cell harvest is ready to be performed for transplant, or to characterise progenitor/precursor populations such as B-cell precursors in Acute lymphoblastic leukaemia (ALL) samples. However, rare CD34+ …
Read MoreStabilisation of T-Cell Activation Markers
Measurement of T-cell activation can be important when assessing immune responses, however cells can become artificially activated over time once removed from the body. TransFix has been used to stabilise activated T-cell populations. We’ve presented a selection of publications to …
Read MoreStabilisation of Circulating Endothelial Progenitor Cells
TransFix stabilises lymphocytes for up to 14 days, but other cell populations have also been shown to be stable with TransFix. One example is Circulating Endothelial and Endothelial Progenitor Cells which have been referenced by multiple papers: TransFix for Delayed …
Read MoreTransFix Stabilisation of Blood Collected on Heparin Anticoagulants
Cytomark have validated TransFix for use with EDTA anticoagulant for lymphocyte phenotyping, however there are publications documenting the successful use of other anticoagulants such as heparin. Below are 2 examples of clinical trials where TransFix has been added to blood …
Read More